Publications for Nil Dizdar-Segrell
Co-author map based on ISI articles 2007-
Journal Articles
Nil Dizdar, Peter Zsigmond, Anita Kullman and Dzeneta Nezirevic
Letter: Untitled
Journal of Neuroscience Methods, 2013, 212(2), 363-363.
|
Peter Zsigmond, Dzeneta Nezirevic Dernroth, Anita Kullman, Lars-Erik Augustinsson and Nil Dizdar
Stereptactic microdialysis of the basal ganglia in Parkinson's disease
Journal of Neuroscience Methods, 2012, 207(1), 17-22.
|
Axel Petzold, Edward J Thompson, Geoffrey Keir, Niall Quinn, Bjorn Holmberg, Nil Dizdar-Segrell, Gregor K Wenning, Olivier Rascol, Eduardo Tolosa and Lars Rosengren
Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 279(1-2), 76-79.
Web of Science® Times Cited: 4 |
Istvan Gati, Olof Danielsson, T Betmark, Jan Ernerudh, Karin Öllinger and Nil Dizdar-Segrell
Effects of inhibitors of the arachidonic acid cascade on primary muscle culture from a Duchenne muscular dystrophy patient
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2007, 77( 3-4), 217-223.
Web of Science® Times Cited: 5 |
B Holmberg, J O Johansson, W Poewe, G Wenning, N P Quinn, C Mathias, E Tolosa, A Cardozo, Nil Dizdar-Segrell, O Rascol and T Slaoui
Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled study
Movement Disorders, 2007, 22(8), 1138-1144.
Web of Science® Times Cited: 16 |
D Nyholm, AIM Nilsson Remahl, Nil Dizdar-Segrell, R Constantinescu, B Holmberg, R Jansson, SM Aquilonius and H Askmark
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
Neurology, 2005, 64(2), 216-223.
Web of Science® Times Cited: 143 |
Robert Kronstrand, Johan Ahlner, Nil Dizdar and Göran Larsson
Quantitative Analysis of Desmethylselegiline, Methamphetamine, and Amphetamine in Hair and Plasma from Parkinson Patients on Long-Term Selegiline Medicatio
Journal of Analytical Toxicology, 2003, 27(3), 135-141.
Web of Science® Times Cited: 16 |
Nil Dizdar, Kerstin Årstrand and Bertil Kågedal
Analysis of L-dopa in human serum
BioTechniques, 2002, 33(5), 1000-1002.
Web of Science® Times Cited: 1 |
Nil Dizdar (Segrell), Anita Kullman and Bertil Kågedal
Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice
Cancer chemotherapy and pharmacology, 2000, 45(3), 192-198.
Web of Science® Times Cited: 4 |
Nil Dizdar (Segrell), Ann-Kathrine Granerus, Ulf Hannestad, Anita Kullman, Å. Ljungdahl, Jan-Edvin Olsson and Bertil Kågedal
L-dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma
Acta neurologica Scandinavica, 1999, 100(4), 231-237.
|
Nil Dizdar (Segrell), Anita Kullman, Björn Norlander, Jan-Edvin Olsson and Bertil Kågedal
Human pharmacokinetics of L-3,4-dihydroxyphenylalanine studied with microdialysis
Clinical Chemistry, 1999, 45(10), 1813-1820.
|
Nil Dizdar (Segrell), Anita Kullman, Bertil Kågedal and Kerstin Årstrand
Effects on interstitial glutathione, cysteine and 5-S-cysteinyldopa of buthionine sulphoximine in human melanoma transplants
Melanoma research, 1997, 7(4), 322.-328.
|
Nil Dizdar (Segrell), Bertil Kågedal, Staffan Smeds and Kerstin Årstrand
A high-sensitivity fluorometric high-performance liquid chromatographic method for determination of glutathione and other thiols in cultured melanoma cells, microdialysis samples from melanoma tissue, and blood plasma.
Melanoma Research, 1991, 1(1), 33-42.
|
Conference Articles
Ph.D. Theses
Ph.D., Lic. Theses
